PMRG's inaugural State of the Industry ("SOI") Survey was conducted in late-2010 to establish a baseline for measuring the attitudes and opinions regarding general biopharmaceutical industry trends and to better understand the evolving role and operations of the marketing research function.  For 2011, PMRG expanded the scope of the survey to include a section dedicated to medical/surgical device and diagnostic professionals.

Given the changes that have taken place over the last twelve months, we are expecting this year’s survey to be even more telling on the role and operation of marketing research and the challenges that lie ahead for the entire healthcare community. To that end, PMRG assembled a dynamic panel of senior manufacturer executives to provide perspective on the results and to discuss the implications on our function and our industry. 

Come armed with your questions, as this session will include a Q&A portion, leading into an industry-wide dialogue that will continue well beyond the conference.

Speaker & Panelist Biographies 

Michele Fuller is the Sr. Director & Global Head - Marketing Sciences at Alcon, a Novartis Company. With over 17 years of experience in the pharmaceutical, biotech and medical device industry, Michele’s current responsibility includes overseeing the Global Marketing Sciences function (Market Research, Market Analytics, Forecasting and Competitive Intelligence) across Alcon’s three Business Franchises (Pharmaceutical, Surgical, and Consumer). Prior to joining Alcon in 2004, Michele managed strategic market research within the biologics sector at Centocor (JNJ), where she supported the development of the company’s commercial strategy in a new specialty market. Michele earned a B.A. magna cum laude in Sociology/Pre-Med from the University of Montana and City University of New York (CUNY).

Thomas “T.J.” Scott, Director, Marketing Sciences at TGaS® Advisors, has extensive experience in commercial insights, marketing research, competitive intelligence, new products planning and forecasting, in addition to experience in nursing, medical publishing, pharmaceutical sales and marketing. T.J. supports TGaS Advisors Marketing Sciences Operations solutions across key functions, including: primary research, secondary information, marketing analytics, forecasting, competitive intelligence, business development, managed care analysis, information management and innovation.  Prior to joining TGaS Advisors, T.J. spent a combined 22 years in pharmaceuticals working for Stuart Pharmaceuticals, ICI, Zeneca, BMS and AstraZeneca. At AZ he headed the New Practices & Innovation Team that conducted adaptive experiments that led to the use of alternative channels for Nexium promotion, and the Oncology Insights Group that launched three new oncology products (Arimidex, Faslodex and Iressa).  T.J. holds a Bachelor of Arts in Advertising degree from the School of Communications at Rowan University, earned a Business Diploma from the Wharton School and is finalizing his thesis for a Master of Sciences Degree in Organizational Dynamic at the University of Pennsylvania.

Todd Francis is Vice President and Head of Commercial Support and Enterprise Marketing at Sanofi US. With over 25 years experience in the pharmaceutical industry, Todd is a senior executive leader with proven general management and P/L experience and expertise in the areas of marketing, payer/employer contracting and negotiations, joint venture negotiations, human resources, personnel management, sales leadership and Commercial model design and execution. Todd has held numerous roles guiding the strategic direction of Sanofi through his work on Commercial Model Evolution, Customer Engagement Strategy, Digital Marketing Strategy and US Transparency.

Len Kanavy is the Vice President, Commercial Business Operations at Genentech and has been there since 2006. In his role, he is responsible for leading the Market Analysis, Forecasting, Marketing & Sales Operations, Data Acquisition, Commercial Training, Business Processes, Thought Leader Management, eMarketing and Commercial Strategy groups.  Len joined Genentech after eighteen years at Novartis Pharmaceuticals, U.S., where he was Vice President of Commercial Operations. He held several leadership roles at Novartis, including Vice President of Business Analysis, Executive Director of Market Analysis, and Director of Specialty Marketing Research & Analysis. He started his career at Novartis as a sales representative and spent five years in various sales positions.

Ariyapadi N. Krishnaraj joined Iroko in 2009 and is responsible for the pre-launch marketing activities for Iroko’s new products in development. Krishna has about 28 years of sales and marketing experience in the pharmaceutical industry. In his previous roles he served as Vice President, Marketing, for Novartis US Vaccines and Executive Director at GlaxoSmithKline where he managed major product franchises in the US, including the antibiotic Augmentin® and the hepatitis vaccine Engerix-B®. He has also served as Senior Vice President, Healthcare Analytics, for Genpact, where he led the building of the analytics practice with major clients such as GlaxoSmithKline, Pfizer, Novartis and Medco.

Since joining GSK in 2002, Judy Stewart has held various marketing positions in the U.S. business, including the PEDIARIX vaccine launch team, the AVANDIA Franchise team, and the LOVAZA Marketing team. Judy also has global commercial strategy experience in the autoimmune and inflammation area for assets in early stage development. Currently she is the Vice President for Cardiovascular Marketing. Her career path at GSK has given her significant experience within many areas of marketing: consumer, professional, KOL development, lifecycle strategy, forecasting, market research and analytics, product launches, and early stage development. Prior to joining GSK, Judy worked in numerous functional areas including market research, sales, sales training and operations within the pharmaceutical industry. She earned a B.S. in Marketing and International Business from the University of Maryland and an M.B.A. from Drexel University.